Blockonomi

TLDR
IonQ and QC Ware test hybrid quantum chemistry for faster drug discovery research
IonQ Forte supports eight-qubit chemistry calculations through Amazon Braket cloud
QC Ware reports interaction-energy results that meet chemical accuracy standards
Promethium links GPU processing with IonQ Forte for advanced molecular modelling
IonQ partnership expands trapped-ion quantum applications in pharmaceutical research
IonQ shares fell 4.02% to $37.73 as QC Ware reported a hybrid chemistry test using IonQ Forte. The project combined GPU processing with trapped-ion quantum computing through Amazon Braket. The test targeted quantum-assisted calculations for early drug discovery work.
IonQ, Inc., IONQ
IonQ Stock Slips as Partnership Expands Quantum Work
IonQ stock extended its decline from about $39.30 and traded at $37.73 during the session. Meanwhile, QC Ware used IonQ Forte to test a workflow for complex molecular interactions. The demonstration focused on research applications rather than broad commercial deployment or clinical use.
QC Ware selected the heme active site of cytochrome P450nor for the test. The enzyme belongs to cytochrome P450, and this family drives much of human drug metabolism. Therefore, the model provided a relevant setting for studying drug binding and metabolic behavior.
Better interaction-energy calculations could improve candidate ranking during pharmaceutical research, according to the companies. Earlier ranking can help research teams focus resources on compounds with stronger predicted characteristics. It can also support earlier metabolic risk checks before compounds enter costly development stages.
IonQ Forte Handles Eight-Qubit Chemistry Calculation
Promethium prepared a 115-atom model containing more than 1,000 molecular orbitals. The platform isolated four strongly correlated orbitals and mapped the active space onto eight qubits. IonQ Forte measured those qubits before Promethium completed final interaction-energy calculations using classical resources.
The workflow calculated electrostatic interaction energy within 0.5 kilocalories per mole of classical benchmarks. That result remained inside the one-kilocalorie-per-mole level commonly linked with chemical accuracy. The companies also reported more than twice the accuracy of the standard classical mean-field method.
IonQ Forte uses trapped ions and provides all-to-all connectivity between qubits. That connectivity enabled complex two-qubit operations without routing steps required by limited-connectivity designs. As a result, the test applied QC Ware’s workflow to another quantum architecture without changing its core approach.
AWS Braket Supports Cloud-Based Quantum Chemistry Test
Amazon Web Services supported the demonstration with cloud computing credits through Amazon Braket. The setup connected QC Ware’s GPU-native Promethium platform with IonQ Forte through cloud infrastructure. This structure showed how classical computing can work with remote quantum hardware inside one workflow.
QC Ware developed Promethium to run chemistry calculations across larger molecular systems and compound sets. QC Ware reports speed gains up to 20 times over conventional CPU-based DFT platforms for selected workloads. Those speed gains target drug discovery, catalysis, materials science, and other chemistry-intensive applications.
For IonQ, the project adds another applied example for its trapped-ion quantum technology. The demonstration expands IonQ’s chemistry presence, and accurate molecular calculations remain resource intensive. However, the test measured technical performance and did not establish clinical effectiveness or broader commercial results.

The post IonQ, Inc. (IONQ) Stock: QC Ware Partnership Targets Quantum Drug Discovery appeared first on Blockonomi.

TLDR
Cadence stock drops 6.84% despite first-pass PCIe 6.0 compliance test success
Cadence PCIe 6.0 subsystem passes all official tests at full 64 GT/s speeds
PCIe 6.0 milestone strengthens Cadence exposure to rising AI data center demand
Cadence adds its PCIe 6.0 solution to the PCI-SIG official Integrators List
TSMC N3-based PCIe 6.0 technology expands Cadence’s high-speed IP portfolio
Cadence Design Systems (CNDS) stock fell 6.84% to $315.62 despite reporting a major PCIe 6.0 technology milestone. The shares extended their decline after trading near $338.78 earlier in the session. Meanwhile, the development strengthened Cadence’s position across high-performance computing and AI data center infrastructure.
Cadence Design Systems, Inc., CDNS
Cadence PCIe 6.0 Technology Passes Major Compliance Test
Cadence confirmed its PCIe 6.0 PHY and controller technology passed official compliance testing on the first attempt. The company implemented the technology using TSMC’s advanced N3 manufacturing process. Moreover, testers evaluated the complete x8 subsystem at the PCIe 6.0 specification’s full 64 GT/s speed.
The subsystem passed every official PCIe 6.0 compliance test during the industry’s first formal testing workshop. As a result, PCI-SIG added Cadence’s complete solution to its official Integrators List. The achievement confirms that the PHY and controller can operate together under demanding industry requirements.
Cadence prepared for the testing process through extensive cooperation with technology partners and testing equipment providers. Furthermore, teams completed interoperability testing before the formal PCI-SIG evaluation began. That preparation helped identify technical issues before Cadence entered the official compliance program.
PCIe 6.0 Strengthens Cadence Position Across Data Centers
PCIe 6.0 technology provides higher bandwidth for modern data centers and high-performance computing systems. Therefore, companies can use the standard across accelerator cards, networking products, and advanced storage systems. Cadence expects these applications to support broader adoption as computing requirements continue expanding.
The technology carries particular importance for large computing facilities handling demanding artificial intelligence workloads. These systems require fast connections between processors, accelerators, storage devices, and networking hardware. Higher PCIe bandwidth can reduce connection bottlenecks across increasingly complex computing systems.
Cadence designed its subsystem to combine performance, power efficiency, and flexible protocol support. The architecture also uses ADC and DSP-based equalization alongside firmware-optimized SerDes operations. Additionally, Cadence included support for recent PCI-SIG engineering updates focused on lower power consumption.
Cadence Expands Semiconductor IP Role Despite CDNS Stock Drop
Cadence already supplies semiconductor design tools and intellectual property across several advanced computing markets. Its PCIe portfolio now extends through technology supporting specifications as advanced as PCIe 7.0. However, the PCIe 6.0 compliance milestone provides customers with a production-ready option available today.
Positron AI has licensed Cadence’s SerDes technology for an inference accelerator designed for transformer workloads. That customer adoption gives Cadence another commercial application for its PCIe 6.0 technology. Meanwhile, successful silicon testing strengthens the technology’s case for use in additional chip development programs.
Cadence developed the certified x8 configuration using TSMC’s N3 manufacturing technology for advanced semiconductor designs. The company now offers the complete PHY and controller subsystem to system-on-chip providers. Therefore, manufacturers can integrate the technology into future data center, enterprise, automotive, and computing products.

The post Cadence Design Systems (CNDS) Stock: Sinks as First Pass PCIe 6.0 Success Strengthens AI Data Center Outlook appeared first on Blockonomi.

TLDR
APEI stock rises 0.74% as Hondros joins American Public University System.
Hondros students gain wider access to bachelor’s, master’s and doctoral degrees.
The combination expands APEI’s healthcare education footprint across three states.
Hondros now operates under American Public University System’s HLC accreditation.
APEI adds another nursing education platform to its career-focused university network.
American Public Education (APEI) expanded its nursing education network after Hondros College of Nursing joined American Public University System. APEI stock traded at $45.99, gaining $0.34, or 0.74%, following the education provider’s latest organizational update. The combination broadens academic pathways while strengthening APEI’s position in career-focused healthcare education.
American Public Education, Inc., APEI
Hondros Joins American Public University System
Hondros College of Nursing now operates as an Academic Unit within American Public University System following the completed combination. The college will operate under the System’s Higher Learning Commission institutional accreditation while maintaining its nursing education focus. Meanwhile, the integration creates broader academic options for current students and future nursing professionals.
The organization will formally operate as Hondros College of Nursing part of American Public University System. However, Hondros will continue serving nursing students through its existing regional campuses and career-focused programs. The change connects Hondros with a larger education network that includes American Public University and American Military University.
The System also includes Rasmussen University, which offers additional nursing and career-oriented academic programs. Hondros students can access more opportunities to continue their education after completing initial nursing qualifications. Those pathways include bachelor’s, master’s, and doctoral nursing programs across institutions operating within the broader System.
APEI Expands Healthcare Education Pathways
Hondros has provided nursing education for more than two decades through a structured approach focused on career progression. The institution has trained thousands of licensed practical nurses and registered nurses during that period. It currently serves students through eight campuses across Ohio, Indiana, and Michigan.
Six Hondros campuses operate in Ohio, while Indiana and Michigan each host one campus. The college also maintains relationships with healthcare organizations and local communities across its operating regions. These connections support practical nursing education and help align training programs with regional healthcare workforce requirements.
Joining American Public University System creates additional progression routes after students complete Hondros nursing programs. Students can continue into advanced nursing education or pursue other career-focused degrees across the System. As a result, the combination links entry-level nursing education with broader professional and academic development opportunities.
American Public Education Strengthens Education Network
American Public University System serves approximately 109,000 students and has more than 250,000 alumni worldwide. Its institutions now include American Military University, American Public University, Rasmussen University, and Hondros College of Nursing. Together, those institutions provide programs focused on career development, public service, healthcare, and other professional fields.
The Higher Learning Commission accredits American Public University System as an institution recognized by the U.S. Department of Education. Hondros now operates under that institutional accreditation as an Academic Unit of the System. Consequently, the combination places Hondros within the same institutional structure supporting APEI’s wider education portfolio.
American Public Education owns the System and operates as a publicly listed career-focused higher education provider. The company concentrates on affordable programs designed for students pursuing workforce-oriented and service-related careers. Hondros adds a specialized nursing platform that expands APEI’s exposure to healthcare education demand.
Hondros Combination Supports APEI’s Growth Strategy
Healthcare workforce shortages continue to increase demand for practical training and advanced nursing education across several regions. Hondros already provides an established entry point for students pursuing practical nursing and registered nursing careers. Its integration gives APEI a stronger platform for connecting those students with advanced academic programs.
The expanded structure may also increase student retention across different stages of nursing education. Graduates can remain within the wider APEI system while advancing toward higher nursing qualifications. Furthermore, the network can serve students seeking additional credentials as their careers and professional requirements develop.
APEI gains another established education brand while Hondros receives access to a wider academic network. The combination also expands APEI’s healthcare education footprint across Ohio, Indiana, and Michigan. With APEI stock at $45.99, the latest move adds another component to the company’s career-focused education strategy.

The post American Public Education (APEI) Stock: Hondros Integration Expands Nursing Education Pathways appeared first on Blockonomi.

TLDR
CrowdStrike launches a new cyber research lab while CRWD shares fall 7.00%.
Cyber Superintelligence Lab targets faster and more automated cyberdefense.
Falcon data gives the new lab access to trillions of daily security events.
Fifteen years of threat intelligence will support CrowdStrike’s new research.
CRWD falls to $214.84 as CrowdStrike expands its long-term security strategy.
CrowdStrike (CRWD) stock dropped sharply as the cybersecurity company launched a new research lab focused on advanced cyberdefense and AI safety. CRWD traded at $214.84, down $16.16, or 7.00%, during the latest session after a steep market decline. The launch expands CrowdStrike’s research strategy while its shares remain under heavy pressure despite the new technology initiative.
CrowdStrike Holdings, Inc., CRWD
CrowdStrike Launches Cyber Superintelligence Lab
CrowdStrike created its Cyber Superintelligence Lab to develop defensive systems for increasingly automated cyber threats across modern enterprise networks. The initiative brings researchers, offensive security specialists, and incident responders into one dedicated research group with a shared development mandate. Dr. Bartley Richardson will lead the lab as CrowdStrike expands work on autonomous security systems and advanced defensive research.
The lab will use CrowdStrike’s security data, threat intelligence, and incident response experience as its main research foundation. Falcon gathers signals from endpoints, cloud workloads, identities, data stores, and security monitoring systems across customer environments. This structure gives researchers a broad dataset for training and testing new defensive technologies under realistic operating conditions.
CrowdStrike wants the lab to develop systems that can learn, adapt, and respond at machine speed during active security incidents. The company expects automated threats to increase as attackers adopt faster tools and more sophisticated methods across digital systems. Therefore, CrowdStrike plans to improve security decisions while reducing the time required to identify, assess, and stop attacks.
Falcon Data Supports CrowdStrike’s Research Push
CrowdStrike’s research effort depends heavily on the large security dataset collected through Falcon across its global customer base. The platform processes trillions of events daily across enterprise systems, cloud infrastructure, identities, and several other security layers. Analysts also classify those signals and connect them with verified results from real attack investigations and response operations.
That process gives CrowdStrike more than raw event volume because the records include known security outcomes and analyst decisions. The company has also accumulated fifteen years of threat intelligence and incident response information from complex security incidents. These records show how attacks developed, which defenses worked, and how security teams contained breaches across different environments.
CrowdStrike can use that context to test new systems against realistic conditions and uncommon attack patterns at greater scale. Researchers can compare automated decisions with verified defensive outcomes, which may help improve accuracy and reduce weak security responses. The dataset also reflects diverse environments where attackers target endpoints, identities, cloud systems, applications, and valuable business data.
New Lab Expands CrowdStrike’s Security Strategy
The new lab strengthens CrowdStrike’s broader effort to automate more parts of enterprise cyberdefense as digital threats evolve rapidly. Falcon already combines threat intelligence, telemetry, detection tools, and automated response within one cloud-based platform for enterprise customers. CrowdStrike now plans to extend that foundation through deeper research into autonomous defensive technology and faster security operations.
The company sees faster response as essential because cyber threats continue to become more automated and difficult to contain. Attackers can use automation for reconnaissance, phishing, malware deployment, credential theft, and other offensive activity at larger scale. CrowdStrike aims to shorten response times while helping its systems learn from verified attack outcomes and past security events.
The initiative also adds another research layer to CrowdStrike’s long-term product strategy and wider enterprise security portfolio. CrowdStrike already covers endpoints, identities, cloud workloads, data protection, and security information management through its Falcon platform. The new lab could connect those areas through faster decision-making, stronger automation, and more coordinated defensive responses across enterprises.

The post CrowdStrike (CRWD) Stock: Cyber Superintelligence Lab Opens New AI Growth Path appeared first on Blockonomi.

Quick Summary
The 10-year Treasury yield reached 4.77%, pressuring technology shares in the S&P 500 and Nasdaq
Crude oil prices rallied 2% amid escalating U.S.-Iran conflict, with Brent crossing $92/barrel
Dell Technologies disclosed a massive $51.3 billion AI server backlog alongside 250% stock appreciation in 2026
Robinhood Markets received an upgrade to Overweight from Morgan Stanley with a $150 target, suggesting 43% potential gains
Apple announced John Ternus as its new CEO, with Tim Cook transitioning to executive chairman
Tuesday marked a turbulent start to September for equity markets. A confluence of rising bond yields, climbing energy prices, corporate earnings releases, analyst rating changes, and a transformative executive transition dominated financial headlines.
Bond Yields Weigh on Equity Markets
The benchmark 10-year Treasury yield advanced to approximately 4.77% during Tuesday’s session. Elevated yields increase financing expenses and enhance the relative appeal of fixed-income securities versus equities.
The tech-heavy Nasdaq declined about 0.7% while the broader S&P 500 retreated roughly 0.4% during morning trading. Major chip manufacturers such as Nvidia, Intel, and AMD experienced downward pressure.
Persistent worries about federal debt levels, entrenched inflation, and projections for sustained elevated interest rates continue driving yields upward.
Crude Prices Rally on Geopolitical Conflict
Oil prices surged following intensified military confrontations between the United States and Iran, heightening anxieties regarding Middle Eastern supply disruptions.
Brent crude climbed past $92 per barrel while West Texas Intermediate neared $88, marking approximately 2% gains for the session.
Elevated crude prices can accelerate inflation through increased fuel and logistics expenses. Energy sector equities benefited from the rally, though growth-oriented and technology stocks encountered additional headwinds.
Dell’s AI Server Backlog Under Investor Scrutiny
Dell Technologies commanded market attention Tuesday as quarterly results approached. Analysts anticipated approximately $45 billion in revenue, propelled predominantly by robust demand for AI-enhanced server infrastructure.
The company commenced the quarter holding an AI server order backlog totaling roughly $51.3 billion. Market participants are eager to assess whether Dell can transform this pipeline into actual sales while preserving profitability.
Dell shares have surged over 250% during 2026. Given such substantial optimism embedded in current valuations, forward guidance for upcoming quarters could prove equally significant as historical performance.
Robinhood Receives Bullish Rating With Substantial Upside Potential
Robinhood Markets gained momentum following Morgan Stanley’s upgrade from Equal Weight to Overweight. The investment bank elevated its price objective from $124 to $150, implying roughly 43% appreciation from prevailing levels.
Morgan Stanley highlighted Robinhood’s decreasing dependence on cryptocurrency trading as the platform diversifies into additional financial services. The analyst emphasized increased user engagement, expanding platform assets, and prediction market offerings as primary catalysts.
Robinhood’s customer base now encompasses approximately 28 million users. Morgan Stanley forecasts the firm will achieve compound annual revenue growth of about 23% extending through 2028.
Apple Ushers in New Leadership Era With Ternus Appointment
One of technology’s most significant executive transitions materialized Tuesday. John Ternus assumed the role of CEO of Apple, succeeding Tim Cook following his 15-year tenure. Cook will continue serving as executive chairman.
Ternus inherits leadership during a critical juncture for the technology giant. Apple confronts mounting pressure to bolster its artificial intelligence capabilities while simultaneously navigating a legal confrontation with OpenAI regarding alleged misappropriation of trade secrets involving ex-Apple personnel.
Market observers will closely monitor Ternus’s strategic direction as Apple navigates an increasingly dynamic technological environment.
The post Market Movers: Treasury Yields Spike, Oil Climbs, and Apple’s Leadership Transition Rocks Markets appeared first on Blockonomi.

Key Takeaways
Bank of America upgraded Microsoft’s price target from $500 to $600 while reaffirming its Buy recommendation
Microsoft’s Azure platform posted 43% growth acceleration in fiscal Q4 2026, improving from the previous quarter’s 39%
The company forecasts 45% Azure expansion for fiscal Q1 2027
Paid Microsoft 365 Copilot user seats exceeded 30 million, with net growth more than doubling from the previous quarter
Year-to-date, MSFT shares have climbed 4.2%, significantly trailing the S&P 500’s approximate 12% advance
After a year of stagnant performance, Microsoft (MSFT) stock may be ready to break out, according to Bank of America. On Tuesday, analyst Tal Liani boosted his valuation target on MSFT to $600 from $500 while maintaining his Buy recommendation. This updated target represents a 19% premium to Tuesday’s trading price of $502.43, which closed down 1% for the session.
Year-to-date gains stand at a modest 4.2%, while the trailing twelve-month return shows a 0.5% decline. By comparison, the S&P 500 has delivered nearly 12% returns during the same timeframe, positioning Microsoft as a notable underperformer. Liani believes current financial metrics now warrant a valuation reassessment.
His bullish stance centers primarily on Azure performance. Microsoft’s cloud infrastructure platform achieved 43% growth during the fiscal fourth quarter ending June 30, representing an acceleration from the previous quarter’s 39% expansion. Management has projected 45% growth for fiscal Q1 2027, signaling continued momentum.
The Copilot AI assistant is also contributing meaningfully. Paid Microsoft 365 Copilot subscriptions crossed the 30 million threshold, with net subscriber additions more than doubling sequentially. Remaining performance obligations surged 84% year-over-year, indicating robust future revenue streams.
Cloud Platform Delivers Measurable Results
BofA’s updated valuation applies a 28x multiple to its calendar year 2027 earnings projection, elevated from the previous 24x multiple. This adjustment reflects accelerated cloud expansion and improved transparency regarding returns from Microsoft’s artificial intelligence infrastructure investments.
Liani highlighted Microsoft’s strategy of deploying a diverse range of AI models, enabling enterprise clients to select the most economically efficient solution for specific use cases.
“Not every workload requires a complex and expensive frontier model, and Microsoft’s approach helps optimize performance while reducing token consumption,” he wrote.
Morgan Stanley analyst Adam Wood shares this optimistic outlook. He maintained his own $600 valuation following late July fiscal Q4 results, noting that the “growth thesis” is “taking shape.” Wood emphasized that Microsoft preserved profit margins despite escalating AI-related expenditures, particularly noteworthy given capital spending reached approximately $41 billion in Q4 alone and $145 billion across the full fiscal year.
Analyst Consensus Supports Upside Potential
Wall Street sentiment broadly favors Microsoft. Among 60 firms monitored by FactSet, the average recommendation on MSFT registers as Buy, with a mean price target of $565.88. BofA’s $600 projection now ranks among the more optimistic forecasts in that distribution.
Seventeen analysts have recently increased their earnings projections for upcoming periods, per InvestingPro data. The stock currently carries a P/E ratio of 28.5 alongside a PEG ratio of 0.89, which InvestingPro characterizes as undervalued when measured against growth prospects.
Meta Platforms has emerged as a significant Azure client, allocating hundreds of millions in annual spending to the platform. Moody’s recently reaffirmed Microsoft’s Aaa credit rating while maintaining a stable outlook.
The post Microsoft (MSFT) Stock Poised for Breakout as BofA Elevates Price Target to $600 appeared first on Blockonomi.

Key Takeaways
CBRS shares declined 3.6% to $177.50 on Tuesday following announcement of a new Finland AI data center partnership
The Mikkeli facility will achieve 165 MW of IT capacity, with initial 50 MW phase already in development
Cathie Wood’s Ark Invest purchased approximately $17 million worth of CBRS shares on Aug. 25, signaling confidence in AI inference
Second quarter revenue reached $180.1 million, representing 74% year-over-year growth, while cloud revenue soared 287% YOY
Analysts maintain consensus “Strong Buy” rating with average price target of $283.91, suggesting approximately 59% upside potential
Shares of Cerebras Systems (CBRS) retreated 3.6% to $177.50 during Tuesday’s trading session, despite the artificial intelligence chip maker unveiling a significant data center partnership in Finland. The stock has tumbled more than 42% over the trailing twelve months and currently trades over 15% beneath its 20-day moving average.
The Finnish collaboration involves Compute Nordic Finland and encompasses a new artificial intelligence data center located in Mikkeli. Planned for phased development, the installation will ultimately deliver 165 MW of contracted IT capacity. Development of the initial 50 MW phase is currently in progress.
Under the agreement’s structure, each service order includes a seven-year commitment, providing Cerebras with stable, long-term infrastructure to power its AI computing platform. The initiative is anticipated to generate employment opportunities throughout the Mikkeli area.
The share price decline accompanying favorable news isn’t particularly unusual. Market conditions were challenging overall, with the Nasdaq (QQQ) sliding 1.5% and the S&P 500 retreating 0.76%. AI infrastructure stocks typically track broader growth sentiment.
From a technical perspective, CBRS is positioned below both its 20-day SMA of $212.57 and its 50-day SMA of $203.90. The MACD indicator sits beneath its signal line accompanied by a negative histogram, suggesting weakening momentum. Critical support exists at $173.50, just above the 52-week low of $160.81.
Ark Invest Increases Position
Despite the stock’s decline, Ark Invest was actively accumulating shares. On Aug. 25, Ark acquired 93,290 CBRS shares distributed across several ETFs, totaling approximately $17.2 million. This follows previous purchases completed earlier in August.
Cathie Wood’s investment rationale focuses on Cerebras’ competitive advantage in AI inference. The company’s CS-4 system reportedly delivers up to 30 times faster inference performance compared to GPU-based solutions. Cerebras is also collaborating with AMD on a disaggregated inference architecture that provides up to five times greater throughput per watt in specific configurations.
The firm maintains strategic partnerships with OpenAI, AWS, and AMD, while simultaneously developing an inference cloud business to complement its hardware revenue streams.
Impressive Growth, Premium Pricing
Cerebras disclosed Q2 revenue of $180.1 million, reflecting 74% year-over-year expansion. Core revenue climbed to $209.9 million, up 103% YOY. Cloud and services revenue exploded 287% YOY to $127.7 million, while core gross margin advanced to 41%.
Leadership increased full-year fiscal 2026 core revenue projections to a range of $880 million to $890 million. Third quarter core revenue guidance was established at $214 million to $216 million.
The company concluded Q2 holding $8.6 billion in cash, restricted cash, and short-term investments, alongside $25.4 billion in remaining performance obligations. Additionally, it has secured more than 600 MW of data center capacity either operational or contractually committed.
The valuation commands a significant premium. With a market capitalization around $42.5 billion against annual sales of approximately $510 million, the price-to-sales multiple stands at 60 times. The company continues reporting GAAP losses.
Wall Street maintains an optimistic stance despite the elevated valuation. Among 11 analysts covering the stock, eight assign “Strong Buy” ratings, one “Moderate Buy,” and two “Hold.”
The consensus price target stands at $283.91. UBS maintains a $330 objective, Morgan Stanley elevated its target to $279, and Wedbush increased its forecast to $290.
The upcoming earnings announcement is projected for November 19, 2026, with analyst consensus anticipating revenue of $214.90 million and an EPS loss of 14 cents.
The post Cerebras (CBRS) Stock Dips Despite Finland AI Data Center Expansion and Ark Invest Buying Spree appeared first on Blockonomi.

Key Takeaways
The European Union has officially designated Roblox as a “very large online platform” under its Digital Services Act, providing regulatory clarity for the company’s 45 million European monthly active users.
Shares experienced upward momentum driven by technical factors and significant short covering after a notable decline in bearish positioning throughout August.
The company’s previously announced $3 billion stock repurchase program continues to provide underlying support for share prices.
Second-quarter results showed a per-share loss of $0.26, which exceeded expectations, though revenue of $1.47 billion fell below the anticipated $1.60 billion mark.
Wall Street maintains a collective “Hold” stance with a mean price target of $60.89; Morgan Stanley recently adjusted its outlook downward from $62 to $55.
Shares of Roblox (RBLX) started trading Tuesday at $41.32, recovering from their recent slump following the European Union’s formal designation of the gaming platform as a “very large online platform” under the Digital Services Act. This regulatory classification establishes a defined compliance framework for the company’s substantial European user base of 45 million monthly active participants, a development that market participants have interpreted positively.
The gaming platform’s equity has faced considerable headwinds throughout the current year. Shares have declined more than 52% since the beginning of 2024, falling from a 12-month peak of $142.00 to a recent trough of $33.88. The company’s current valuation stands at approximately $27.52 billion.
The recent price recovery extends beyond just the European regulatory announcement. Technical dynamics have also contributed significantly. Bears substantially reduced their positions following aggressive shorting activity in August, and this unwinding of short positions provided additional upward momentum.
Management’s $3 billion stock repurchase authorization, which received board approval in May, permits the acquisition of up to 9.5% of shares outstanding. The board’s willingness to allocate capital toward buybacks at current price levels communicates management’s belief that shares are trading below intrinsic value.
Quarterly Results Fall Short on Revenue
When Roblox disclosed its latest quarterly performance on July 30th, the company reported a per-share loss of $0.26 for the second quarter, surpassing analyst expectations which had anticipated a $0.34 loss. Nevertheless, revenue totaling $1.47 billion came in below the Street’s $1.60 billion projection.
Despite the shortfall, revenue demonstrated year-over-year growth of 8.3%. During the comparable period last year, the company recorded a per-share loss of $0.41, indicating improvement in bottom-line performance. Current analyst projections forecast a full-year per-share loss of $1.39.
The company’s balance sheet reflects a debt-to-equity ratio of 7.82 alongside a net margin of negative 17.60%. Technical indicators show the 50-day moving average at $45.92 and the 200-day moving average at $51.39, both positioned above current trading levels.
Institutional Positioning and Wall Street Perspectives
The Public Employees Retirement System of Ohio acquired 181,051 RBLX shares during the second quarter, representing an investment of approximately $9.85 million. Institutional shareholders and hedge funds maintain ownership of 94.46% of outstanding shares.
Additional second-quarter purchasers included Kinetic Partners Management LP, which established a position valued at roughly $6.57 million, and S&CO Inc., which initiated a holding worth about $921,000.
Wall Street sentiment remains divided. Morgan Stanley reduced its price objective from $62 to $55 while maintaining an “overweight” rating. DA Davidson established a $40 target. Arete Research projects a $95 price point with a “buy” recommendation. Piper Sandler assigns a “neutral” rating with a $47 target.
Among 31 analysts providing coverage, 12 recommend buying, 15 suggest holding, and 3 advise selling. The average price target across all analysts is $60.89.
Insider transactions merit attention. Chief Financial Officer Naveen Chopra divested 17,509 shares at $37.96 on August 20th, totaling approximately $664,641. Matthew Kaufman, another insider, similarly sold 14,904 shares at the identical price. Both transactions were executed to satisfy tax liabilities associated with vesting equity awards.
Cumulative insider selling during the trailing 90-day period reached 168,213 shares with an aggregate value of roughly $6.83 million.
The post Roblox (RBLX) Stock Climbs After EU Digital Services Act Classification appeared first on Blockonomi.

TLDR
Navitas sets September shipments for its first U.S.-made Gen 5 GaNFast wafers
GlobalFoundries partnership brings Navitas Gen 5 GaNFast into U.S. production
Navitas expands U.S. GaN supply with first Gen 5 wafer shipments in September
Gen 5 GaNFast rollout targets computing, industrial and defense power markets
NVTS falls 3.93% as Navitas advances U.S. Gen 5 GaNFast wafer production plans
Navitas Semiconductor will begin shipping its first U.S.-made Gen 5 GaNFast wafers in September through GlobalFoundries. The milestone moves Navitas deeper into domestic power semiconductor production for data centers, computing, industrial systems, and defense applications. NVTS traded at $11.14, down 3.93%, after a sharp intraday drop and a partial recovery.
U.S. Gen 5 GaNFast Production Moves Forward
Navitas developed its fifth-generation GaNFast platform for production at GlobalFoundries’ 200mm GaN-on-silicon facility in Burlington, Vermont. The manufacturing plan expands domestic capacity for advanced gallium nitride power devices used in high-efficiency electrical systems. It also gives Navitas a U.S.-based production source for future GaNFast generations.
The companies formed a long-term strategic partnership in November 2025 to accelerate domestic GaN development and manufacturing. Since then, Navitas has adapted its device designs and process technology for GlobalFoundries’ manufacturing platform. The collaboration combines Navitas’ power semiconductor designs with GlobalFoundries’ established high-volume production capabilities.
The first product family will include 650-volt GaN FETs across several on-resistance specifications for different power requirements. Navitas expects resistance options of 11, 18, 50, 120, and 150 milliohms within the initial lineup. This range targets power systems that require different balances between efficiency, switching performance, size, and thermal control.
September Wafers Start a Broader Sampling Schedule
Navitas expects the first Gen 5 wafers to leave the Vermont production line during September. Internal samples should follow in October as the company moves through testing and qualification work. Strategic customer samples are planned before year-end, supporting wider evaluation across targeted markets.
The September shipment marks the first production step under the Navitas and GlobalFoundries manufacturing partnership. It also brings Navitas’ newest GaNFast architecture into a domestic commercial foundry for the first time. That transition gives the company a clearer path from design development to U.S.-based wafer production.
Navitas designed the platform for data center power, high-performance computing, industrial electrification, and national security systems. These applications need efficient power conversion as electricity demand rises across advanced computing and industrial equipment. GaN devices can support smaller power systems while reducing energy losses during high-frequency switching.
Navitas Builds on Long-Term GaN and SiC Development
Navitas has developed gallium nitride power products since 2014 and also operates a silicon carbide technology portfolio. The company holds more than 300 issued and pending patents across GaN and SiC technologies. Its portfolio covers device structures, process design kits, integrated power circuits, control features, sensing, and protection functions.
The Gen 5 program extends that technical base into a manufacturing process designed for 200mm GaN-on-silicon wafers. Larger wafer formats can support greater production scale when fabrication yields and customer demand reach commercial targets. GlobalFoundries adds manufacturing infrastructure that can support higher volumes as Navitas expands customer qualification.
The U.S. production effort also gives Navitas another supply option for markets that value domestic semiconductor sourcing. That factor matters for computing, industrial, and defense programs that require dependable component availability and traceable manufacturing. The September wafer shipment therefore adds a production milestone alongside the company’s broader technology and supply-chain strategy.

The post Navitas Semiconductor (NVTS) Stock: First Gen 5 GaNFast Wafers Set for September appeared first on Blockonomi.

Key Highlights
The London Stock Exchange (LSE) has formed a strategic alliance with Payward, the parent entity behind cryptocurrency exchange Kraken, to digitize equity shares from the top 100 LSE-listed corporations.
These digital share tokens, branded as xStocks, will be accessible to investors spanning more than 110 nations, though UK residents remain ineligible.
The xStocks platform has already facilitated over $40 billion in cumulative trading activity, with approximately $20 billion processed through blockchain settlement.
The LSE intends to feature xStocks on LSE 24, its forthcoming around-the-clock trading platform, pending regulatory clearance.
Both organizations are evaluating the possibility of launching native blockchain-issued securities that would possess identical rights to conventional shares.
The London Stock Exchange has unveiled a strategic collaboration with Payward, which operates the Kraken cryptocurrency platform, to introduce blockchain-based tokenized versions of British equities to international market participants.
LSE Partners With Kraken Parent Payward, Plans to List xStocks in 2027
The London Stock Exchange (LSE) announced a partnership with Kraken parent company Payward to explore connecting regulated capital markets infrastructure with on-chain ecosystems and developing a UK tokenized… pic.twitter.com/MuZZIAFUe4
— Wu Blockchain (@WuBlockchain) September 1, 2026
Under this agreement, equity stakes in the 100 most capitalized companies trading on the LSE will become available via Payward’s xStocks digital platform. Every xStock token maintains a one-to-one correspondence with an actual underlying share, establishing a direct equivalence between digital tokens and traditional securities.
These blockchain-based equity representations will be open to qualified investors across more than 110 jurisdictions worldwide. However, investors residing in the United Kingdom cannot currently access xStocks due to existing regulatory constraints.
xStocks represents an established offering rather than a novel product launch. The platform has generated cumulative trading volumes exceeding $40 billion, with close to $20 billion of those transactions finalized directly through blockchain networks. The service currently serves a user base surpassing 200,000 token holders.
LSE 24 Trading Platform Positioned for Tokenized Equity Listings
This collaboration extends well beyond merely adding UK equities to the xStocks ecosystem. Contingent upon obtaining regulatory authorization, the London Stock Exchange intends to feature xStocks on LSE 24, its proposed continuous trading facility scheduled to commence operations during the first six months of 2027.
Julia Hoggett, Chief Executive of the LSE, emphasized that tokenization initiatives must evolve while maintaining the confidence and protections inherent in regulated marketplaces. Arjun Sethi, co-Chief Executive of Payward, characterized the agreement as a convergence of traditional regulated finance with modern blockchain technology.
The London Stock Exchange has been actively pursuing strategies to engage emerging investor demographics, particularly retail market participants accustomed to continuous trading availability. The exchange has also faced scrutiny from Elliott Management, an activist investment firm that revealed a significant ownership position in February 2026.
Investigating Native Blockchain Share Issuance
In addition to the xStocks initiative, Payward and the LSE announced plans to investigate the direct issuance of securities on blockchain infrastructure. This proposed framework would involve creating securities natively on distributed ledgers, with these digital assets being completely interchangeable with traditional shares and conferring identical ownership rights.
This approach represents a departure from the existing xStocks structure, where digital tokens are supported by conventional shares maintained within traditional custodial frameworks.
Payward has been broadening the utility of its xStocks offering. In July 2026, Kraken introduced functionality allowing eligible international customers to utilize specific xStocks as collateral for derivatives and leveraged trading activities. Eligible assets encompass tokenized representations of major corporations including Apple, Nvidia, and Tesla.
The London Stock Exchange is not pursuing tokenized equities in isolation. Deutsche Boerse acquired a $200 million equity position in Kraken during April. Robinhood has introduced tokenized stock offerings across the European Union, while Coinbase continues expanding its presence in this emerging sector.
Shares of London Stock Exchange Group experienced a decline of approximately 2% during early trading hours in London on Tuesday.
No precise launch timeline has been disclosed for the initial UK-listed xStocks beyond an indication of availability within the forthcoming weeks.
The post LSE Partners With Kraken’s Parent Company to Launch Tokenized UK Equities appeared first on Blockonomi.

TLDR
Intuitive Machines wins a new contract for two IM 300 spacecraft platforms.
New IM 300 order expands Intuitive Machines into a broader customer segment.
LUNR stock falls 4.30% to $14.70 despite the latest spacecraft contract win.
IM 300 platform supports flexible payloads, propulsion, and constellation use.
Palo Alto facility supports serial production as spacecraft demand expands.
Intuitive Machines (LUNR) secured a new contract for two IM 300 spacecraft platforms from a new, undisclosed customer in another market. The award expands the company’s customer base and opens another important market segment for its modular satellite platform. However, LUNR stock fell 4.30% to $14.70, extending a steady intraday decline from above $15.30 during the latest trading session.
Intuitive Machines, Inc., LUNR
New IM 300 Contract Broadens Intuitive Machines Customer Reach
The contract adds a new customer category today for Intuitive Machines and strengthens demand for its IM 300 platform. The company designed the spacecraft bus for flexible missions and shorter delivery schedules across several commercial space markets. The new order also shows the platform can support heavier payloads with higher power requirements across demanding missions.
Intuitive Machines built the IM 300 around a modular structure that supports different payloads, missions, and operating profiles across markets. Its standardized interfaces can serve commercial, civil, and national security missions without requiring customers to develop a new spacecraft design. As a result, customers can adjust the platform for mission needs while retaining the platform’s common spacecraft architecture across programs.
The IM 300 also supports optical and radio-frequency links for communication between satellites operating together within a network. Customers can select chemical or electric propulsion based on orbit, maneuvering needs, and expected mission duration and operating conditions. Meanwhile, its low unit mass allows operators to place several spacecraft on one launch and reduce overall constellation deployment costs.
Intuitive Machines Expands Satellite Manufacturing Capacity
Intuitive Machines produces the IM 300 at its high-volume satellite manufacturing facility in Palo Alto, California, for repeat production. The site supports serial spacecraft production and differs from facilities designed mainly for individual, one-off satellite development programs. This production model allows the company to add orders while maintaining schedules for customers already moving through its manufacturing pipeline.
The company combines its production infrastructure with an established supplier network to support faster spacecraft assembly, testing, and delivery. That structure supports repeat platform production and could help Intuitive Machines serve more customers across mission categories and orbital markets. It also gives the company a broader manufacturing base as demand grows for smaller, configurable spacecraft platforms worldwide today.
Intuitive Machines operates across spacecraft manufacturing, communications, mission operations, networks, and ground infrastructure and related space services across several markets. Its systems serve missions in Earth orbit, cislunar space, and deep space for commercial, civil, and national security customers. The latest IM 300 award therefore expands its satellite platform business while adding another customer beyond its existing market base.

The post Intuitive Machines, Inc. (LUNR) Stock: New IM 300 Contract Expands Spacecraft Customer Base appeared first on Blockonomi.

Key Highlights
LongRange Capital has finalized the purchase of Pizza Hut from Yum! Brands (YUM), with Mainland China operations remaining separate.
The pizza chain records roughly $10 billion in global system-wide sales annually.
Eduardo Luz assumes the role of Interim CEO at Pizza Hut following the ownership transition.
LongRange Capital operates as a private equity investment firm specializing in consumer goods, technology, and data sectors.
The purchase price and specific financial details remain undisclosed.
Shares of Yum! Brands (YUM) declined 0.68% following the finalization of the Pizza Hut sale to private equity firm LongRange Capital. The transaction encompasses all Pizza Hut locations and operations excluding those in Mainland China.
Established in 1958 in Wichita, Kansas, Pizza Hut has evolved into an international pizza powerhouse, generating approximately $10 billion in system-wide annual revenue.
Eduardo Luz has been appointed as the Interim Chief Executive Officer for Pizza Hut. His leadership begins as the restaurant chain embarks on a new chapter as an independent entity separated from the Yum! Brands corporate umbrella.
“As an independent entity, our complete attention is directed toward Pizza Hut’s customers, franchise partners, and the dedicated teams who represent our brand daily,” Luz stated in an official announcement.
Bob Berlin founded LongRange Capital and currently holds the position of Managing Partner. The investment firm emphasizes its commitment to extended investment horizons when developing consumer-oriented enterprises.
According to Berlin, the company intends to support franchise operators and channel resources into brand development. “Our commitment lies in empowering our franchise partners and allocating appropriate capital to ensure Pizza Hut consistently delivers exceptional food and customer experiences,” Berlin explained.
Implications for Yum! Brands
This divestiture removes Pizza Hut from a restaurant collection that continues to feature KFC and Taco Bell. Prior to this sale, Yum! Brands ranked among the world’s most expansive fast food conglomerates with these three major chains consolidated under single ownership.
The move to divest Pizza Hut aligns with an industry-wide pattern of major restaurant corporations consolidating and focusing their brand collections. Yum! continues to maintain separate Chinese market operations through Yum China, which became an independent entity in 2016.
The monetary value of the Pizza Hut sale has not been made public. The acquisition price paid by LongRange Capital remains confidential.
LongRange Capital’s Strategic Vision
LongRange Capital maintains investment portfolios spanning consumer goods and services sectors, technology and data analytics, and specialized industrial segments. The firm utilizes adaptable, extended-duration capital supported by institutional investment partners.
Digital transformation has been identified as a key strategic priority by the new ownership. Pizza Hut currently processes more than half of its worldwide orders through digital platforms, a capability the brand has significantly expanded in recent years.
The chain operates Hut Rewards in the United States, a customer loyalty initiative that awards points based on purchase amounts. This type of direct consumer engagement will likely receive increased emphasis under new management.
Pizza Hut holds a pioneering position in digital commerce. The company is widely recognized for processing the first documented online food purchase in 1994.
LongRange has not disclosed detailed timelines or specific performance objectives for its Pizza Hut ownership. The firm indicated its strategy centers on operational enhancements and digital advancement to generate what it described as “sustainable growth.”
YUM stock traded down 0.68% when the transaction completion was announced on September 1, 2026.
The post Yum! Brands (YUM) Stock Slides as Pizza Hut Sale to LongRange Capital Finalizes appeared first on Blockonomi.

Key Highlights
Piper Sandler shifted its stance on Tempus AI to Overweight from Neutral, boosting the price target from $56 to $76
Shares of TEM increased approximately 2.1-2.5% during Tuesday’s premarket session
Three key catalysts were identified: the acquisition of Personalis, favorable INTerpath-001 study results, and FDA clearance of the xT CDx test
Under the Personalis transaction terms, each share is valued at $16.25 in Tempus Class A stock, with an option for up to 50% cash payment
Canaccord Genuity maintained its Buy recommendation with an $80 target after the August 31 S-4 filing
Shares of Tempus AI (TEM) advanced between 2.1% and 2.5% during Tuesday’s premarket session following an upgrade by Piper Sandler analyst David Westenberg, who moved his rating from Neutral to Overweight while lifting his price objective to $76 from the prior $56 level.
This upgrade represents a notable shift in Westenberg’s perspective on the company. His earlier Neutral stance reflected concerns that TEM’s market valuation was being propelled more by artificial intelligence enthusiasm than by the tangible results from its diagnostics operations and data platforms.
However, that assessment has evolved. Westenberg now points to three distinct growth catalysts that have emerged with greater clarity, strengthening his conviction in the company’s underlying business fundamentals.
The primary catalyst involves the upcoming Personalis acquisition. This transaction will provide Tempus with access to a tumor-informed minimal residual disease (MRD) platform, which Piper Sandler characterizes as a distinctive asset within the oncology diagnostics landscape.
The S-4 filing for this transaction was submitted on August 31. According to the terms disclosed, each Personalis share carries a $16.25 valuation, to be settled in Tempus Class A stock based on a ratio calculated from the Tempus share price. Additionally, Tempus retains the flexibility to substitute cash for as much as half of the stock consideration.
INTerpath-001 Study Results Enhance Strategic Positioning
The second catalyst stems from favorable results in the INTerpath-001 study. According to Westenberg, this outcome elevates the strategic importance of both Personalis and Tempus AI as the tumor sequencing provider for what may emerge as a novel therapeutic category.
These study results bolster Tempus’s competitive standing in the MRD sector during a period when the Personalis acquisition remains under review, establishing a more defined trajectory in the clinical sequencing marketplace.
FDA Approval Removes Critical Barrier for xT CDx
The third catalyst is the FDA’s approval of the tumor-only xT CDx test. According to Piper Sandler, this regulatory clearance eliminates a significant obstacle for Tempus as it works toward achieving unified ADLT pricing across its xT product portfolio.
The analyst noted that xF, a companion product, may pursue a comparable regulatory pathway during the latter half of 2027. Achieving unified ADLT pricing would materially influence Tempus’s revenue structure for these diagnostic products.
Canaccord Genuity also provided commentary after the August 31 S-4 filing, confirming its Buy rating on TEM while maintaining an $80 price target.
This positions Canaccord’s target modestly above Piper Sandler’s updated $76 projection, with both investment firms now carrying constructive views on the equity.
The August 31 S-4 filing stands as the latest official disclosure concerning the Personalis deal, making the transaction terms accessible for investor evaluation.
The post Piper Sandler Boosts Tempus AI (TEM) Stock Rating to Overweight with $76 Target appeared first on Blockonomi.

Key Takeaways
Shares of Alumis plummeted approximately 56% following the announcement that its Phase 2b LUMUS study of envudeucitinib failed to achieve primary and secondary goals in the broader lupus patient cohort.
The study included 408 participants but did not reach its primary goal of measuring disease activity improvement at the 48-week mark.
Patients identified as IFNGS-high in a prespecified analysis demonstrated significant positive outcomes, though this subset was underrepresented in the overall study population.
The biotech firm continues to target a Q4 2026 submission for a New Drug Application covering envudeucitinib in plaque psoriasis, supported by encouraging Phase 3 data.
Management plans to meet with regulatory authorities to discuss launching a Phase 3 trial specifically targeting lupus patients with high interferon gene signatures.
Alumis shares experienced a devastating collapse on Tuesday, falling approximately 56% after the biotechnology company disclosed that its Phase 2b LUMUS clinical trial evaluating envudeucitinib failed to demonstrate efficacy in individuals suffering from moderate-to-severe systemic lupus erythematosus (SLE).
At one point during the trading session, the stock plummeted as much as 57.86%. Such a dramatic single-session decline represents a significant blow for any biotechnology firm.
The clinical study recruited 408 participants and evaluated disease activity utilizing the British Isles Lupus Assessment Group-based Composite Lupus Assessment, abbreviated as BICLA, at the 48-week timepoint. This served as the trial’s primary measure of success. Unfortunately, it was not achieved.
Additional secondary measures in the complete patient population also failed to reach statistical significance.
However, the company highlighted one encouraging finding. A predetermined subset of patients exhibiting elevated interferon gene signatures, designated as IFNGS-high, demonstrated substantial clinical improvement on both the primary measure and crucial secondary outcomes.
ALUMIS $ALMS JUST COLLAPSED 55% AFTER ITS LUPUS CLINICAL TRIAL FAILED$ALMS erased $1.5B in valuation today after its 408-patient Phase 2b LUMUS trial missed its primary endpoint despite being described as “potentially pivotal.”
The drug showed promise in patients with… pic.twitter.com/Bpfpv2gKMQ
— Limitless Finance (@trylimitlessfin) September 1, 2026
Patients classified as IFNGS-high represent the majority of moderate-to-severe SLE diagnoses. The challenge was that this group was unexpectedly underrepresented in the current study, which negatively impacted the overall trial outcomes.
According to Alumis, envudeucitinib demonstrated favorable tolerability across the study duration. No unexpected safety concerns emerged during the trial.
Pharmacodynamic analysis also verified substantial dose-dependent modulation of the interferon signaling pathway, with the maximum dose of 40mg administered twice daily producing the greatest suppression effect.
Alumis’ Strategic Path Forward
Management indicated plans to engage in discussions with regulatory agencies regarding the development of a Phase 3 clinical program specifically designed for the IFNGS-high patient segment.
Alumis emphasized that no targeted oral treatment options currently exist for SLE, which the company views as compelling justification to continue advancing development efforts in this therapeutic area.
The psoriasis development program continues to advance as planned. Alumis maintains its timeline to file a New Drug Application for envudeucitinib in moderate-to-severe plaque psoriasis during the fourth quarter of 2026.
This regulatory submission builds upon favorable results from the company’s Phase 3 ONWARD clinical program evaluating the drug in plaque psoriasis.
Understanding Alumis’ Broader Context
Envudeucitinib functions as an oral allosteric inhibitor targeting tyrosine kinase 2, commonly referred to as TYK2. The therapeutic mechanism involves modulating immune signaling pathways regulated by IL-23, IL-17, and Type I interferon.
The compound’s mechanism of action remains consistent whether treating lupus or psoriasis, which explains why the positive IFNGS-high subset results continue to generate interest among investors and industry analysts monitoring the development pipeline.
Prior to Tuesday’s selloff, the company maintained a market capitalization of approximately $2.99 billion. Year-to-date, the stock had delivered returns exceeding 123% before the trial announcement.
Average daily share volume typically hovered around 1.29 million shares before the clinical results became public.
Technical sentiment indicators had assigned a Hold rating to the stock before the announcement emerged.
The post Alumis (ALMS) Stock Crashes Over 50% Following Lupus Trial Disappointment appeared first on Blockonomi.

TLDR
Amazon shares fall 2.06% as an institutional firm cuts its position by 2.3%
AWS revenue jumps 36.7% to $42.2 billion, while Amazon reports $200.6B revenue
Amazon posts $5.75 EPS, beating the cited $1.82 analyst estimate for the quarter
Amazon stock tests $252.50 support after falling sharply from the $259.77 level
Institutional funds hold 72.2% of Amazon shares amid recent ownership changes
Amazon (AMZN) shares fell to $254.41, down 2.06%, after declining sharply from the $259.77 area. The decline pushed the price toward $252.50, the nearest support level on the chart. Meanwhile, $255 and $257.50 remained key resistance areas above the current price.
Amazon.com, Inc., AMZN
Institutional Stake Reduction
Capital Investment Services of America reduced its Amazon position during the second quarter. The firm sold 2,975 shares, cutting its holding by 2.3% to 126,495 shares. The remaining position carried a value of about $30.1 million at the quarter’s end.
The sale added detail to Amazon’s shareholder activity during the quarter. Institutional funds held about 72.2% of Amazon’s shares, according to the provided filing data. In addition, company insiders sold 70,589 shares worth about $18.3 million during the past 90 days.
The institutional sale came as Amazon continued reporting operating growth across its main businesses. However, the transaction represented a small reduction from the firm’s remaining 126,495-share position. Therefore, the filing showed a change in one institutional holding rather than a broad ownership shift.
Amazon Revenue and AWS Growth
Amazon reported $200.6 billion in quarterly revenue, up 19.6% from the same period last year. Meanwhile, Amazon Web Services revenue rose 36.7% to $42.2 billion during the quarter. The results showed growth across Amazon’s business and cloud unit.
The company also reported quarterly earnings per share of $5.75. That figure exceeded the $1.82 analyst estimate cited in the provided information. Amazon recorded higher earnings per share alongside increased revenue and AWS sales.
The operating figures provide context for the share price decline and institutional transaction. Amazon’s revenue growth continued while AWS posted a faster year-over-year increase during the quarter. At the same time, the stock remained below $255 after its latest decline.
Price Levels and Shareholder Activity
Amazon’s price action showed selling pressure after the stock fell from $259.77. The decline brought shares near $252.50, establishing that level as immediate support. A move above $255 would return the stock to the nearest resistance zone shown.
The next marked resistance level sits near $257.50, while $259.77 represents the upper level shown. However, the shares remained at $254.41 at the reported market time. Therefore, the stock traded between the nearest support and resistance levels after the decline.
The Capital Investment Services transaction formed part of Amazon’s shareholder activity. Institutional funds continued holding a large share, while insiders also recorded recent sales. Meanwhile, Amazon’s latest results showed higher revenue, stronger AWS sales, and earnings above the cited estimate.
The post Amazon (AMZN) Stock:Drop as Institutional Investor Trims Holdings appeared first on Blockonomi.

Key Takeaways
Major US equity indexes declined Tuesday amid rising Treasury yields and elevated energy prices
Treasury yields surged, with the 10-year note reaching 4.75%, marking the highest intraday point since January 2025
Crude oil prices climbed above $92 per barrel following attacks on tankers near the Strait of Hormuz
Technology shares led the decline, with the Nasdaq dropping nearly 0.9% amid concerns over AI sector financing costs
Economic data revealed modest growth in job vacancies during July, while manufacturing activity continued its expansion streak
American equity markets began September on a down note Tuesday, pressured by climbing Treasury yields, escalating energy costs, and growing geopolitical uncertainty surrounding Iran that kept market participants cautious.
The Dow Jones Industrial Average retreated approximately 0.4%, shedding roughly 208 points. The S&P 500 declined 0.5%, while the Nasdaq Composite experienced a steeper fall of close to 0.9%.
E-Mini S&P 500 Sep 26 (ES=F)
Treasury Yields Climb to Extended Highs
The benchmark 10-year Treasury note yield advanced to 4.75% during Tuesday’s trading session, representing its peak intraday level since January 2025. Meanwhile, the 30-year bond yield touched 5.27%, approaching multi-decade highs, before moderating slightly.
Yields just won't stop.
You know it's bad when bond market is quite literally ignoring the US Treasury.
24 hours later and the 10Y Note Yield is now pushing into 4.80%, its highest since January 2025.
That's another +20 basis points since the low seen after the US Treasury's… pic.twitter.com/XUOD5PQQC6
— The Kobeissi Letter (@KobeissiLetter) September 1, 2026
Elevated yields translate to increased borrowing costs. This development particularly impacts technology and artificial intelligence firms that have relied heavily on debt financing to support substantial capital expenditure initiatives.
Market strategists at Citi highlighted that current market positioning shows unprecedented exposure to the AI sector, amplifying sensitivity to fluctuations in government bond yields.
According to cross-asset analyst Nic Puckrin, the “summer party for risk assets is over,” advising market participants to “prepare for a sell-off, especially in long-duration equities like tech and AI.”
Energy Markets Compound Investor Concerns
Brent crude futures pushed above $92 per barrel Tuesday. Reports from Bloomberg indicated that two oil tankers sustained damage while navigating the exit from the Strait of Hormuz, intensifying anxieties about potential escalation in the US-Iran standoff.
Rising oil prices compound inflationary pressures, potentially reinforcing market expectations that the Federal Reserve might implement additional interest rate increases.
The technology sector suffered significant losses, declining 1%. Notable underperformers in the S&P 500 included CrowdStrike, Lumentum, and Palo Alto Networks.
Equities entered September with strong double-digit gains year-to-date alongside improving earnings forecasts. However, September traditionally represents the most challenging month for equity performance, with 2025’s edition carrying additional risk factors.
Regarding economic indicators, the Job Openings and Labor Turnover Survey revealed a marginal increase in available positions during July. Manufacturing sector activity maintained its expansion trend for an eighth consecutive month, although momentum decelerated slightly.
Upcoming quarterly reports from Dell and Palo Alto Networks are anticipated to provide insights into corporate capital allocation toward technology infrastructure and cloud computing services.
The Nasdaq concluded trading down 233 points. The S&P 500 shed approximately 40 points. The Dow finished just over 200 points lower.
The post Markets Decline as Treasury Yields Surge to January 2025 Highs appeared first on Blockonomi.

Key Highlights
The pharmaceutical giant reached a fresh 52-week peak of $29.09 during Tuesday’s session, closing at $28.75
Second quarter 2026 results surpassed Wall Street projections: earnings per share of $0.77 versus consensus of $0.68, revenues of $15.03B against estimates of $14.42B
Management increased full-year 2026 revenue projections after the quarterly performance
Settlement reached on more than 6,000 federal lawsuits related to Depo-Provera, eliminating significant legal uncertainty
Wall Street analysts maintain a “Hold” consensus with a mean target price of $28.28
Shares of Pfizer reached a new 52-week peak of $29.09 during Tuesday’s trading session, ultimately settling at $28.75. This performance represents approximately 20% gains year-to-date, marking a significant recovery for the pharmaceutical company that has been working through the aftermath of declining COVID-related revenues over the past two years.
Trading volume reached more than 8.3 million shares, exceeding normal activity levels and indicating heightened investor attention.
The upward momentum follows a robust second quarter 2026 financial report. The company delivered adjusted earnings per share of $0.77, exceeding analyst consensus estimates of $0.68 by nine cents. Total revenue reached $15.03 billion, surpassing the anticipated $14.42 billion.
Compared to the corresponding period in the previous year, revenue increased by 2.6%. While modest, this positive growth trajectory has captured market attention.
In response to the strong quarterly performance, Pfizer elevated its full-year 2026 EPS outlook to a range between $2.80 and $3.00. Wall Street analysts are currently projecting the company will achieve $2.98 for the complete fiscal year.
Erste Group Bank also increased its fiscal 2026 earnings per share projection for Pfizer following the quarterly results, contributing to the favorable sentiment surrounding the report.
Legal Uncertainty Eliminated with Depo-Provera Agreement
A significant development this week involves the conclusion of Depo-Provera-related litigation. The pharmaceutical company achieved a confidential settlement agreement encompassing more than 6,000 federal lawsuits alleging connections between the contraceptive and intracranial meningioma.
While specific financial details remain undisclosed and the company acknowledged no wrongdoing, removing this legal uncertainty from the equation carries meaningful weight. The investment community had been monitoring this litigation closely, and its conclusion eliminates a substantial overhang.
Cancer Treatment Portfolio Gains Traction
Pfizer’s cancer treatment division continues attracting analyst focus. Padcev currently leads growth within this segment, while the company maintains additional development programs including PF-08634404 that may bolster future revenue streams.
Expanded label indications in oncology are being monitored as potential counterbalances to challenges in other business areas as legacy products encounter generic competition.
Regarding shareholder returns, the company distributed $0.43 per share quarterly on September 1st to investors recorded as of July 24th. This translates to an annualized dividend of $1.72 and yields approximately 6%.
This attractive yield has positioned PFE as a popular topic among investors seeking income-producing holdings while technology and artificial intelligence stocks maintain elevated valuations.
Wall Street opinion remains divided. Royal Bank of Canada elevated the stock from underperform to sector perform in June, whereas HSBC downgraded it from buy to hold in July while reducing its price target from $32 to $28. Cantor Fitzgerald maintains a neutral stance with a $27 objective, and Wolfe Research continues an underperform rating with a $26 target.
The aggregate consensus stands at “Hold” with a mean price objective of $28.28, marginally below the stock’s current trading level.
Institutional ownership comprises 68.36% of outstanding shares. Multiple smaller investment funds established new positions during the first and second quarters of 2026.
The stock’s 50-day moving average currently sits at $25.62 while the 200-day moving average rests at $26.30, both positioned considerably beneath the present price level.
The post Pfizer (PFE) Stock Surges to 52-Week Peak Following Strong Q2 Results and Major Legal Settlement appeared first on Blockonomi.

Key Takeaways
MongoDB is scheduled to announce fiscal Q2 2027 results after Tuesday’s closing bell, with Wall Street projecting earnings per share of $1.61 alongside revenue totaling $735.2 million.
Shares have climbed 34% in the last 30 days, reaching $453.37 and approaching the 52-week peak of $473.10.
The company’s Atlas cloud database platform represents between 72% and 79% of overall revenue, making it the critical performance indicator.
Wall Street consensus maintains a Buy rating with an average price target of $446.26, now marginally below the current trading price.
Recent analyst upgrades include Cantor Fitzgerald’s $540 target and Guggenheim’s $560 target, driven by favorable channel feedback.
MongoDB is set to unveil its fiscal second quarter 2027 financial performance following Tuesday’s market close. Wall Street forecasts call for earnings of $1.61 per share on top-line revenue reaching $735.2 million.
These projections indicate a sequential jump of 22% in earnings per share and 7% revenue expansion compared to the previous quarter, during which MongoDB exceeded bottom-line projections by approximately 11%.
On a year-over-year basis, the anticipated figures reflect 61% earnings growth and 24% revenue advancement.
Shares of MDB currently trade at $453.37, representing a 34% gain throughout the past month and hovering near the 52-week maximum of $473.10.
The average analyst price objective stands at $446.26, derived from 41 individual estimates, suggesting shares are now marginally overvalued relative to Wall Street’s consensus view.
Rating distribution includes: 32 Buy recommendations, eight Hold positions, and a single Sell rating.
Atlas Performance Remains Central to Investment Thesis
Market attention will concentrate on Atlas, MongoDB’s fully-managed cloud database offering. This service generates between 72% and 79% of aggregate revenue and serves as the primary catalyst behind the company’s expansion trajectory.
Company leadership previously guided toward 26% Atlas expansion for the current quarter. Analyst consensus generally anticipates outperformance by two to three percentage points, aligning with historical patterns.
Should Atlas growth approach the 29%-30% territory observed in earlier quarters, shares will likely experience upward momentum. Conversely, results tracking closer to the low-20% range projected for the fiscal year’s latter half could trigger selling pressure.
During the previous reporting period, MongoDB secured 96 additional enterprise clients with annual spending exceeding $100,000, elevating that cohort to 2,895 total. Investors seek confirmation that this metric continues its upward trajectory.
Artificial Intelligence Workload Adoption Under Scrutiny
The secondary focal point entering Tuesday’s announcement centers on artificial intelligence initiatives. MongoDB has developed Vector Search capabilities, integrated Voyage AI-powered retrieval systems, and embedded native AI agent functionality throughout its platform.
Analysts are looking for concrete evidence that these capabilities are transitioning from experimental implementations into revenue-generating production environments. Management commentary regarding AI-focused customer expansion and enterprise deployment will receive significant attention.
Across the broader data management and analytics software category, investor sentiment has trended positively. Comparable companies have advanced approximately 14.2% on average over the trailing month, with MongoDB exceeding that benchmark at 24.8%.
For context, DigitalOcean delivered 28.6% year-over-year revenue growth in its recent quarter, surpassing expectations by 0.9%, while Commvault achieved 11.4% growth, beating by 1.2%. Both experienced post-earnings declines despite exceeding estimates.
Forward guidance for the fiscal year’s second half represents another critical component of Tuesday’s market reaction. Cantor Fitzgerald elevated its price objective to $540 and Guggenheim increased its target to $560, though concerns persist regarding potential Atlas deceleration to 21%-23% during the upcoming quarters.
Should management elevate second-half Atlas projections above 25%, shares could extend recent gains. Conversely, unchanged or disappointing guidance may trigger a rapid reversal of the recent rally.
In the first fiscal quarter, MongoDB delivered EPS of $1.32 compared to the $1.19 consensus, accompanied by revenue of $687.6 million, exceeding forecasts by 3.6%. The company elevated its full-year Atlas growth guidance by 200 basis points during that announcement.
EPS projections have remained unchanged over the past week but have experienced modest downward revision over the trailing 60-day period. Revenue estimates have demonstrated stability across both timeframes.
The post MongoDB (MDB) Stock: Investor Expectations Ahead of Tuesday’s Q2 Report appeared first on Blockonomi.

Key Highlights
AAPL shares climbed 2.6% as John Ternus assumed the chief executive position, with Tim Cook transitioning to executive chairman.
Under Cook’s leadership spanning 15 years, Apple’s valuation soared from $350 billion to more than $4.5 trillion.
An analyst initiated a buy rating on Apple shares coinciding with the executive transition announcement.
The tech giant has scheduled a significant product unveiling for September 9, anticipated to showcase the iPhone 18 series and potentially its inaugural foldable device.
AAPL bucked broader market weakness, with the S&P 500 declining 0.4% and Nasdaq falling 0.7% during the session.
Shares of Apple reached an intraday peak of $325.86 on Tuesday, marking a 2.6% increase from the previous session’s closing price of $316.85, as John Ternus formally assumed leadership of the technology behemoth.
The leadership handoff concluded Tim Cook’s remarkable 15-year run at the company’s helm. In his farewell message posted on X, Cook wrote: “Sending lots of love to the Apple community on my last day as CEO. Thank you for being a constant source of inspiration.”
At 50 years old, Ternus brings 25 years of Apple experience to the CEO position, most recently holding the role of senior vice president of hardware engineering. His portfolio included directing engineering efforts for flagship products such as the iPad, AirPods, and Apple Watch.
The leadership succession had been communicated to markets well ahead of time, resulting in what appeared to be a seamless transition. Market participants seem reassured by Ternus’s appointment, given his extensive product development credentials.
Cook’s performance metrics speak volumes. Between August 2011 and Monday’s market close, AAPL shares skyrocketed 2,274%. An initial $1,000 stake at the beginning of Cook’s leadership would have grown to $23,740, not accounting for dividend payments.
During Cook’s tenure, Apple’s market capitalization expanded by $4.32 trillion, positioning it as the world’s second-largest corporation behind Nvidia. Trailing twelve-month revenue reached $467 billion, representing a 364% increase from the Steve Jobs era.
“Cook’s strength was execution, turning an already iconic company into one of the most profitable and valuable businesses the world has ever seen,” said Jay Woods, chief market strategist at Freedom Capital Markets.
Adding to the stock’s upward momentum, a Wall Street analyst issued a fresh buy recommendation on AAPL shares on the same day as the leadership change.
The Road Ahead for New CEO Ternus
Ternus takes control of a company positioned at a critical juncture in product development. Apple has confirmed a September 9 launch event, widely expected to introduce the iPhone 18 family. Industry observers are also speculating about the potential debut of Apple’s first foldable smartphone.
Apple recently introduced updated Mac mini configurations in late August, featuring its groundbreaking 2-nanometer M6 processor. Additionally, the company has announced plans for an AI-enhanced Siri upgrade scheduled for September release.
“At 50, Ternus is roughly the same age Cook was when he replaced Jobs, but his engineering and product background offers Apple something different as it searches for its next big innovation and plays catch-up in AI,” Woods noted.
Broader Market Performance
Apple’s positive performance contrasted sharply with overall market weakness. The S&P 500 declined 0.4%, the Dow Jones Industrial Average slipped 0.2%, and the Nasdaq Composite retreated 0.7% during Tuesday’s trading.
The session lacked significant macroeconomic releases or Federal Reserve statements to influence trading. Apple’s stock movement was driven purely by company-specific developments.
Cook will maintain ties to the organization he led for a decade and a half in his new capacity as executive chairman.
The upcoming September 9 product showcase will mark Ternus’s debut major appearance as chief executive.
The post Apple (AAPL) Stock Surges 3% as Ternus Officially Becomes CEO appeared first on Blockonomi.

Key Takeaways
The Dollar Spot Index climbed 0.2% to reach 99.61, maintaining proximity to its two-week peak
July’s U.S. job openings remained steady at 7.3 million, indicating continued labor market strength
Financial markets now assign a 74% probability to a Federal Reserve rate increase on September 17
The euro declined 0.20% to $1.1592 following Eurozone core inflation data showing a drop to 2.4%
The Japanese yen saw modest gains but remained near 159.85, dangerously close to the 160 intervention threshold
The greenback maintained its position near a two-week peak on Tuesday following the release of employment data that reinforced market expectations for an upcoming Federal Reserve interest rate increase.
The Dollar Spot Index advanced 0.2% to 99.61, extending last week’s momentum that followed Fed Chair Kevin Warsh’s hawkish remarks at the Jackson Hole economic symposium.
US Dollar Index (DX-Y.NYB)
Employment Report Bolsters Dollar Strength
The Job Openings and Labor Turnover Survey for July revealed that U.S. job vacancies remained essentially unchanged at 7.3 million positions. The vacancy rate stayed constant at 4.4%, while new hires decreased to 5.1 million from the previous month’s 5.3 million.
JOLTS job openings 7.271MM, Exp. 7.313MM, Last 7.182MM (revised down from 7.359MM)
— zerohedge (@zerohedge) September 1, 2026
Voluntary separations also held stable at 3.1 million, suggesting workers maintain sufficient confidence to pursue new opportunities. This indicates the employment market hasn’t deteriorated to the extent some analysts anticipated.
At Jackson Hole, Warsh emphasized the Federal Reserve’s continued commitment to bringing inflation down to its 2% objective. With core PCE inflation currently at 3.3%, the central bank clearly has additional tightening to pursue.
Financial derivatives markets now indicate a 74% likelihood of a 25 basis point rate increase at the Fed’s September 17 policy meeting. This represents a significant jump from the mere 34% probability recorded before Warsh’s speech.
The benchmark 10-year Treasury yield increased 3 basis points to 4.80%, marking its highest level since January 2025. Higher yields support dollar strength by expanding the interest rate differential with other nations.
European and Japanese Currencies Face Headwinds
The euro declined 0.20% to $1.1592. Eurozone headline inflation accelerated to 3.3% year-over-year in August, rising from July’s 2.9%. However, core CPI, excluding volatile energy and food prices, moderated to 2.4% from 2.5%.
This divergence presents a challenge for European Central Bank policymakers ahead of their September policy meeting. The more subdued core inflation reading may constrain the ECB’s ability to pursue tightening parallel to the Federal Reserve.
The Japanese yen appreciated 0.10% to 159.85 against the dollar, hovering just beneath the 160 threshold that has historically prompted government currency market interventions.
U.S. Treasury Secretary Scott Bessent urged Bank of Japan Governor Kazuo Ueda to increase interest rates during the G20 gathering in Asheville. Bessent stated he possesses “information that the market doesn’t have” regarding Japanese currency stabilization initiatives.
Critical Economic Releases Ahead
Derivatives markets have elevated the likelihood of a Bank of Japan rate increase at its September 17-18 policy meeting to approximately 88%. Japan’s 10-year government bond yield climbed 5 basis points to 3.00%, reaching its highest point in three decades.
Crude oil prices remained steady near $91.10 per barrel, supported by U.S.-Iran military tensions, contributing additional uncertainty to global financial markets.
The ADP private sector employment report is scheduled for Wednesday, with the comprehensive August Nonfarm Payrolls report arriving Friday. U.S. August consumer price index data, expected next week, will be the final significant economic indicator before the Fed’s policy decision.
An inflation reading exceeding expectations could drive September rate hike probabilities even higher and provide additional momentum to the dollar’s recent advance.
The post U.S. Dollar Maintains Strength as Labor Market Data Reinforces September Fed Rate Hike Prospects appeared first on Blockonomi.